Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The cross-talk of lung and heart complications in COVID-19: Endothelial cells dysfunction, thrombosis, and treatment
Langjiao Liu, Haijiao Jing, Xiaoming Wu, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 9

Showing 9 citing articles:

Lessons we learned during the past four challenging years in the COVID-19 era: pharmacotherapy, long COVID complications, and vaccine development
Parisa Ghasemiyeh, Soliman Mohammadi‐Samani
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 6
The role of the endothelium in severe acute respiratory syndrome coronavirus 2 infection and pathogenesis
Rainha Passi, Mairi Brittan, Andrew H. Baker
Current Opinion in Physiology (2023) Vol. 34, pp. 100670-100670
Open Access | Times Cited: 10
Severe and post-COVID-19 are associated with high expression of vimentin and reduced expression of N-cadherin
Esra Şafak Yılmaz, Dilek Yılmaz, Ercan Çaçan
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Coagulopathy and thromboembolic events a pathogenic mechanism of COVID‐19 associated with mortality: An updated review
Parastoo Yousefi, Saber Soltani, Goli Siri, et al.
Journal of Clinical Laboratory Analysis (2023) Vol. 37, Iss. 11-12
Open Access | Times Cited: 7
Innate Immunity in Cardiovascular Diseases—Identification of Novel Molecular Players and Targets
Wolfgang Poller, Bettina Heidecker, Enrico Ammirati, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 1, pp. 335-335
Open Access | Times Cited: 6
Molnupiravir: an antiviral drug against COVID-19
Bhavarth Dave, Kashvi C. Shah, Mehul R. Chorawala, et al.
Archives of Virology (2023) Vol. 168, Iss. 10
Closed Access | Times Cited: 6
Impact of first and second/third wave of COVID-19 pandemic on post-acute cardiovascular outcomes in Lombardy
Luisa Ojeda‐Fernández, Marta Baviera, Andreana Foresta, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 1
Innate Immunity in Cardiovascular Diseases – Identification of Novel Molecular Players and Targets
Wolfgang Poller, Bettina Heidecker, Enrico Ammirati, et al.
(2022)
Open Access | Times Cited: 1
Innate Immunity in Cardiovascular Diseases – Identification of Novel Molecular Players and Targets
Wolfgang Poller, Bettina Heidecker, Enrico Ammirati, et al.
(2022)
Open Access | Times Cited: 1
Page 1

Scroll to top